A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.Published in:Endocrine (1355008X), 2021, v. 73, n. 3, p. 588, doi. 10.1007/s12020-021-02660-xBy:Pires, Carolina;Marques, Inês Jorge;Dias, Daniela;Saramago, Ana;Leite, Valeriano;Cavaco, Branca MariaPublication type:Article